On two points I beg to differ. Alan is not alone in believing agreement is possible on “public stockholding” and special safeguard mechanism by the year-end ministerial conference. …
None other than new WTO head @NOIweala also said it in last week’s General Council: “On Agriculture, let us identify a few things we can deliver such as PSH [“public stockholding”], SSM [special safeguard mechanism] …”
2. It’s true that members have agreed there should be new safeguards (SSM) for developing countries, but ONLY as part of an overall market access deal, not stand-alone
It’s misleading to say only rich countries can use the existing safeguard (SSG)
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. Pfizer supply delayed. Still waiting for approval: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
Pfizer/BioNTech, Moderna mRNA vaccinations ongoing. Pfizer supply delayed. Still waiting for approval: AstraZeneca, Curevac and Novavax. Switzerland has ordered over 30m doses for 8m people
YES: The text (latest December 2008) does include broad cuts for overall trade-distorting domestic support (OTDS), further disciplines if more distorting (AMS), and different treatment for developed v developing countries
1. Fixed end date (2030)
2, Target for worldwide trade-distorting support entitlements: cut by half 3. How the variations are achieved within the target is left open
4. Broad reference to “all forms” of trade/production-distorting support. So, no distinction between “AMS” entitlements (usually big, eg US, EU, Japan etc) and “de minimis” (“smaller”, for everyone, but now big for India, China).
1. Would the UK joining #CPTPP be beneficial? Yes, but the benefits would be limited—distance does matter, even with services, and CPTPP is thin on services.